Home > Financial Ratios > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Fixed Capital/Sales

    Back to All Ratios
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

ERIS LIFESCIENCES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.821.801.110.750.80

What is the latest Fixed Capital/Sales ratio of ERIS LIFESCIENCES ?

The latest Fixed Capital/Sales ratio of ERIS LIFESCIENCES is 1.82 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.82
Mar20241.80
Mar20231.11
Mar20220.75
Mar20210.80

How is Fixed Capital/Sales of ERIS LIFESCIENCES Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.82
1.11
Mar2024 1.8
62.16
Mar2023 1.11
48.00
Mar2022 0.75
-6.25
Mar2021 0.8 -

Other Financial Ratios of ERIS LIFESCIENCES


Compare Fixed Capital/Sales ratio of peers of ERIS LIFESCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ERIS LIFESCIENCES ₹18,261.2 Cr -0.8% -10.2% 6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


ERIS LIFESCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ERIS LIFESCIENCES

-0.8%

-10.2%

6%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses